Aarskog-Scott syndrome: a novel mutation in the FGD1 gene associated with severe craniofacial dysplasia

Eur J Pediatr. 2014 Oct;173(10):1373-6. doi: 10.1007/s00431-014-2317-3. Epub 2014 Apr 27.

Abstract

Aarskog syndrome (AAS) is an X-linked human disease that affects the skeletal formation and embryonic morphogenesis and is caused by mutations in the FGD1 gene. Patients typically show distinctive skeletal and genital developmental abnormalities, but a broad spectrum of clinical phenotypes has been observed. We report here on the clinical and molecular analysis of a family that reveals a novel FGD1 mutation in a 9-year-old boy displaying extreme craniofacial dysplasia associated with attention deficit hyperactivity disorder. Sequencing of FGD1 revealed a novel mutation in exon 7 at position c.1468 C > T in the index patient, leading to a stop codon in the highly conserved RhoGEF gene domain. His mother and maternal grandmother were also found to be heterozygous for this FGD1 mutation.

Conclusion: Our results identify a novel mutation of FDG1 in a family with Aarskog syndrome and underscore the phenotypical variability of this condition.

Publication types

  • Case Reports

MeSH terms

  • Attention Deficit Disorder with Hyperactivity / complications
  • Attention Deficit Disorder with Hyperactivity / genetics
  • Child
  • Dwarfism / complications
  • Dwarfism / genetics*
  • Face / abnormalities*
  • Female
  • Genetic Diseases, X-Linked / complications
  • Genetic Diseases, X-Linked / genetics*
  • Genetic Markers
  • Genitalia, Male / abnormalities*
  • Guanine Nucleotide Exchange Factors / genetics*
  • Hand Deformities, Congenital / complications
  • Hand Deformities, Congenital / genetics*
  • Heart Defects, Congenital / complications
  • Heart Defects, Congenital / genetics*
  • Humans
  • Male
  • Pedigree
  • Phenotype
  • Point Mutation*

Substances

  • FGD1 protein, human
  • Genetic Markers
  • Guanine Nucleotide Exchange Factors

Supplementary concepts

  • Aarskog Syndrome